Townsend Beverley A
School of Law, University of KwaZulu-Natal, Durban, South Africa.
BMC Med Ethics. 2020 Oct 6;21(1):95. doi: 10.1186/s12910-020-00527-w.
Human genome editing technologies offer much potential benefit. However, central to any conversation relating to the application of such technologies are certain ethical, legal, and social difficulties around their application. The recent misuse, or inappropriate use, by certain Chinese actors of the application of genome editing technologies has been, of late, well noted and described. Consequently, caution is expressed by various policy experts, scientists, bioethicists, and members of the public with regard to the appropriate use of human germline genome editing and its possible future effect on future generations.
As concerns about the applications of heritable genome editing have grown, so too have the questions around what is to be done to curtail 'rogue actors'. This paper explores various ways in which to regulate genomic editing that are socially beneficial, while being cognisant of legal and ethical principles and rights values. This is done by evolving regulatory frameworks across jurisdictions in an attempt to raise issues, address common principles, and set responsible standards for stewardship of the novel technology.
It is suggested that robust and concrete regulatory measures be introduced that are culturally and contextually sensitive, inclusive, appropriate, and trustworthy - and are based on public empowerment and human rights objectives. Doing so will ensure that we are perfectly positioned to harness and promote the benefits that novel technologies have to offer, while safeguarding public health and curtailing the ambitions of rogue actors. This it is acknowledged is no easy task, so, as a point of departure, this paper sets out a path forward by means of certain, practical recommendations - by constructing genome editing regulation in a manner that both fulfils the desire to better progress human health and that can withstand legal and ethical scrutiny. The following observations and recommendations are made: Firstly, that a solution of effective, legitimate governance should consist of a combination of national and supranational legislative regulation or 'hard' law, in combination with 'soft' ethics, firmly anchored in and underpinned by human rights values. Second, that efforts to support legal and ethical solutions should be rigorous, practical, and robust, contribute to a reaffirmation of human rights in a contextually sensitive manner, and be transnational in reach. Lastly, that greater harmonisation across jurisdictions and increased public engagement be sought. This it is proposed will address the question of how to implement a normative framework which in turn can prevent future rogue actors.
人类基因组编辑技术具有诸多潜在益处。然而,任何有关此类技术应用的讨论,其核心都涉及围绕其应用的某些伦理、法律和社会难题。近期,某些中国行为主体对基因组编辑技术应用的滥用或不当使用,近来已受到广泛关注和报道。因此,众多政策专家、科学家、生物伦理学家及公众对人类生殖系基因组编辑的恰当使用及其对后代可能产生的影响表示谨慎。
随着对可遗传基因组编辑应用的担忧与日俱增,围绕如何遏制“不良行为者”的问题也日益凸显。本文探讨了各种对基因组编辑进行监管的方式,这些方式既有利于社会,又能兼顾法律和伦理原则以及权利价值观。这是通过在不同司法管辖区不断完善监管框架来实现的,旨在提出问题、探讨共同原则,并为这项新技术的管理设定负责任的标准。
建议引入强有力且具体的监管措施,这些措施应在文化和背景方面具有敏感性、包容性、恰当性和可信度,并基于公众赋权和人权目标。这样做将确保我们能够充分利用和推广新技术带来的益处,同时保障公众健康并遏制不良行为者的企图。诚然,这并非易事,因此,作为出发点,本文通过某些切实可行的建议,规划了一条前进的道路——以一种既能满足推动人类健康取得更大进展的愿望,又能经受住法律和伦理审查的方式构建基因组编辑监管。以下是一些观察结果和建议:首先,有效的合法治理解决方案应包括国家和超国家立法监管或“硬”法与“软”伦理的结合,并牢固地扎根于人权价值观并以其为支撑。其次,支持法律和伦理解决方案的努力应严谨、务实且有力,以在具体情境中敏感的方式促进对人权的重申,且具有跨国影响力。最后,应寻求不同司法管辖区之间更大程度的协调以及公众更多的参与。建议这将解决如何实施一个规范性框架的问题,进而能够防止未来出现不良行为者。